Tempus AI
| Formerly | Tempus Labs |
|---|---|
| Company type | Public |
| Nasdaq: TEM | |
| Industry | Health technology |
| Founded | 2015 |
| Founder | Eric Lefkofsky |
| Headquarters | 600 West Chicago Avenue, Chicago, Illinois, US |
Key people | Eric Lefkofsky (CEO) |
Number of employees | 2,300 (2024) |
| Website | tempus |
Tempus AI, Inc. (formerly Tempus Labs) is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."